-
Product Insights
Red Hat Inc Partner Ecosystem Profile
GlobalData's new report titled "Red Hat Inc Partner Ecosystem Profile " serves as a crucial resource for analyzing the partner landscape of Red Hat Inc. It identifies the company's partners across various countries and regions, and tracks over 70 data fields including IT solution areas of interest, business fundamental data (such as revenue and employee bands), partner engagement signing country, focused verticals, and more.It is based on data and information gathered from a range of sources including company websites, press...
-
Innovation Ranking
Innovation Ranking – Red Avenue New Materials
Red Avenue New Materials Group Co Ltd (Red Avenue) carries out the research, development, production, sales and trading of fine chemical materials. Its product portfolio includes phenolic resins for rubber, rubber additives, p-tert-butylphenol, PTA, oxalic acid, butanediol, butylene adipate, butylene terephthalate and diisobutylene. The company also produces tackifying resins, adhesive resins, and reinforcing resins. Red Avenue's products are mainly applied in tires, as well as hoses, adhesive tapes, rubber shoes and other rubber products. Its products find application in plastic...
-
Innovation Ranking
Innovation Ranking – Red Star Macalline Group Corp Ltd
Red Star Macalline Group Corp Ltd (Red Star), a subsidiary of Red Star Macalline Home Group Co Ltd, is engaged in the operation of owned and leased portfolio shopping malls. The company operates owned and leased portfolio shopping malls; managed shopping malls; sales of merchandise and related services; and other. Its owned and leased portfolio shopping malls carries out leasing floor areas to the tenants and providing comprehensive and continuous operation and management support to them. Red Star-managed shopping malls...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KL-1333M in Myoclonic Epilepsy with Ragged Red Fibers (MERRF) Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KL-1333M in Myoclonic Epilepsy with Ragged Red Fibers (MERRF) Syndrome report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KL-1333M in Myoclonic Epilepsy with...
-
Product Insights
Shanghai BG/ Shanghai Dongyuan RED – Taopu Science and Technology Smart City (Unit W06-1401) Plot 049-01, 050-01, 051-01 Residential Facility – Shanghai
The Shanghai BG/ Shanghai Dongyuan RED – Taopu Science and Technology Smart City (Unit W06-1401) Plot 049-01, 050-01, 051-01 Residential Facility – Shanghai involves the construction of a residential facility on a site area of 3.01ha and a GFA of 75,316m2 in Taopu Science and Technology Smart City of Shanghai. Equip yourself with the essential tools needed to make informed and profitable decisions with our Shanghai BG/ Shanghai Dongyuan RED – Taopu Science and Technology Smart City (Unit W06-1401) Plot...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KL-1333M in Mitochondrial Diseases
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KL-1333M in Mitochondrial Diseases report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KL-1333M in Mitochondrial Diseases Drug Details: KL-1333M is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tafenoquine Succinate in Tick-Borne Diseases
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tafenoquine Succinate in Tick-Borne Diseases report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tafenoquine Succinate in Tick-Borne Diseases Drug Details: Tafenoquine Succinate (Arakoda)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Mitapivat Sulfate in Alpha Thalassaemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Mitapivat Sulfate in Alpha Thalassaemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mitapivat Sulfate in Alpha Thalassaemia Drug Details: Mitapivat sulfate (Pyrukynd)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sonpiretigene Isteparvovec in Retinitis Pigmentosa (Retinitis)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sonpiretigene Isteparvovec in Retinitis Pigmentosa (Retinitis) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sonpiretigene Isteparvovec in Retinitis Pigmentosa (Retinitis) Drug Details: Sonpiretigene...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Mitapivat Sulfate in Beta Thalassaemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Mitapivat Sulfate in Beta Thalassaemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mitapivat Sulfate in Beta Thalassaemia Drug Details: Mitapivat sulfate (Pyrukynd)...